You are on the money. I have heard the same

First 7 Last

Share
Profile

Follow
wzessbnoeg

72 Posts.

14

19/11/21

10:59

Post #: 57696717
Share

Originally posted by WilliamD: ↑

Unsubstantiated information. I heard no SPP. All is taken up by Insto. At premium (cir. 50c). There would be a suspension for several months for the cap raise and the acquisition to come through (inc. initial integration). Once re-listed (cir. 1Q21), existing shares will be freely traded while the cap raise shares will be subject to escrow (cir. 6-12 months).

During the suspension, if business development could achieve important milestones (particularly securing the 1st one or two 7-figure contracts), then it would be very timely.

If you recall, there are three legs of growth - business development (SRJ's current technology), M&A, and hydrogen related technology research. If the above comes true, then I can envisage the first two legs will deliver share price growth in 2022. The hydrogen leg might start contributing to share price growth in 2023.

Back to the point regarding participants in the cap raise. I heard it would be A$100m+. Given time criticality and size of the raise, I understand why Insto's only. But retail holders shouldn't feel missed out given (i) it is at premium and (ii) if the merger is successful, we would be rewarded.

Last but not least, even with this acquisition, my investment thesis remains unchanged - this would be a medium / long-term play. People with < 12 month horizon (at this juncture) might need to manage return expectation. But people with 2-3 year horizon might be rewarded quite nicely.

Expand

You are on the money. I have heard the same

SRJ Price at posting: 43.0¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COB

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

OJC

SPC to merge with Original Juice Co and Nature One Dairy

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

There are more pages in this discussion • 18 more messages in this thread...

First 7 Last

Add SRJ (ASX) to my watchlist

(20min delay)
Last 4.9¢		Change -0.003(5.77%)		Mkt cap ! $29.48M

Open	High	Low	Value	Volume
5.2¢	5.2¢	4.9¢	$18.70K	374.0K

Buyers (Bids)

No.	Vol.	Price($)
1	171000	4.9¢

Sellers (Offers)

Price($)	Vol.	No.
5.2¢	56622	1

View Market Depth

No.	Vol.	Price($)
1	171000	0.049
1	217000	0.046
1	78000	0.045
1	85000	0.041
1	100000	0.035

Price($)	Vol.	No.
0.052	56622	1
0.055	200000	1
0.056	94879	2
0.057	165968	2
0.058	290000	2

Last trade - 15.59pm 02/10/2024 (20 minute delay)

SRJ (ASX) Chart

You are on the money. I have heard the same

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

SPC to merge with Original Juice Co and Nature One Dairy

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

You are on the money. I have heard the same

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

SPC to merge with Original Juice Co and Nature One Dairy

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News